• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽与新城疫病毒融合蛋白七肽重复区域序列的相互作用。

Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.

作者信息

Young J K, Li D, Abramowitz M C, Morrison T G

机构信息

Department of Chemistry, Colgate University, Hamilton, New York, USA.

出版信息

J Virol. 1999 Jul;73(7):5945-56. doi: 10.1128/JVI.73.7.5945-5956.1999.

DOI:10.1128/JVI.73.7.5945-5956.1999
PMID:10364347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC112656/
Abstract

Typical of many viral fusion proteins, the sequence of the Newcastle disease virus (NDV) fusion protein has several heptad repeat regions. One, HR1, is located just carboxyl terminal to the fusion peptide, while the other, HR2, is located adjacent to the transmembrane domain. The structure and function of a synthetic peptide with a sequence from the region of the NDV HR1 region (amino acids 150 to 173) were characterized. The peptide inhibited fusion with a half-maximal concentration of approximately 2 microM; however, inhibition was observed only if the peptide was added prior to protease activation of the fusion protein. This inhibition was virus specific since the peptide had minimal effect on fusion directed by the Sendai virus glycoproteins. To explore the mechanism of action, the potential HR1 peptide interaction with a previously characterized fusion inhibitory peptide with a sequence from the HR2 domain (J. K. Young, R. P. Hicks, G. E. Wright, and T. G. Morrison, Virology 238:291-304, 1997) was characterized. The results demonstrated an interaction between the two peptides both functionally and directly. First, while the individual peptides each inhibit fusion, equimolar mixtures of the two peptides had minimal effect on fusion, suggesting that the two peptides form a complex preventing their interaction with a target protein. Second, an HR2 peptide covalently linked with biotin was found to bind specifically to HR1 peptide in a Western blot. The structure of the HR1 peptide was analyzed by nuclear magnetic resonance spectroscopy and found to be an alpha helix.

摘要

许多病毒融合蛋白都具有典型特征,新城疫病毒(NDV)融合蛋白的序列有几个七肽重复区域。其中一个,HR1,位于融合肽的羧基末端,而另一个,HR2,位于跨膜结构域附近。对一段来自NDV HR1区域(氨基酸150至173)的合成肽的结构和功能进行了表征。该肽抑制融合的半数最大浓度约为2 microM;然而,只有在融合蛋白经蛋白酶激活之前添加该肽时才观察到抑制作用。这种抑制具有病毒特异性,因为该肽对仙台病毒糖蛋白介导的融合作用极小。为了探究其作用机制,对潜在的HR1肽与先前表征的来自HR2结构域的融合抑制肽(J.K.扬、R.P.希克斯、G.E.赖特和T.G.莫里森,《病毒学》238:291 - 304,1997)之间的相互作用进行了表征。结果表明这两种肽在功能上和直接相互作用方面都存在相互作用。首先,虽然单个肽各自都抑制融合,但两种肽的等摩尔混合物对融合的影响极小,这表明这两种肽形成了一个复合物,阻止它们与靶蛋白相互作用。其次,在蛋白质印迹中发现与生物素共价连接的HR2肽能特异性结合HR1肽。通过核磁共振光谱分析了HR1肽的结构,发现其为α螺旋。

相似文献

1
Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.肽与新城疫病毒融合蛋白七肽重复区域序列的相互作用。
J Virol. 1999 Jul;73(7):5945-56. doi: 10.1128/JVI.73.7.5945-5956.1999.
2
Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion.靶向新城疫病毒融合蛋白的病毒多肽抑制剂的设计与表征
J Mol Biol. 2005 Dec 2;354(3):601-13. doi: 10.1016/j.jmb.2005.08.078. Epub 2005 Oct 10.
3
Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.基于七肽重复序列2的肽抑制禽肉瘤和白血病病毒A亚群感染并鉴定出一种融合中间体。
J Virol. 2004 Dec;78(24):13430-9. doi: 10.1128/JVI.78.24.13430-13439.2004.
4
Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.新城疫病毒融合蛋白膜近端七肽重复序列的突变分析
Virology. 2001 Oct 25;289(2):343-52. doi: 10.1006/viro.2001.1123.
5
Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.融合肽和相邻七肽重复序列中的突变会抑制新城疫病毒融合蛋白的折叠或活性。
J Virol. 2001 Sep;75(17):7934-43. doi: 10.1128/jvi.75.17.7934-7943.2001.
6
Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus.新城疫病毒F蛋白七肽重复区域的六螺旋束组装及特性分析
J Gen Virol. 2002 Mar;83(Pt 3):623-629. doi: 10.1099/0022-1317-83-3-623.
7
Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus.严重急性呼吸综合征(SARS)冠状病毒刺突蛋白七肽重复区域HR1和HR2的特征分析及融合核心结构模型设计
Biochemistry. 2004 Nov 9;43(44):14064-71. doi: 10.1021/bi049101q.
8
Structure and function study of paramyxovirus fusion protein heptad repeat peptides.副粘病毒融合蛋白七肽重复序列的结构与功能研究
Arch Biochem Biophys. 2005 Apr 15;436(2):316-22. doi: 10.1016/j.abb.2005.02.004.
9
The fusion protein core of measles virus forms stable coiled-coil trimer.麻疹病毒的融合蛋白核心形成稳定的卷曲螺旋三聚体。
Biochem Biophys Res Commun. 2002 Dec 20;299(5):897-902. doi: 10.1016/s0006-291x(02)02761-4.
10
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.严重急性呼吸综合征相关冠状病毒刺突蛋白中七肽重复序列1和2区域之间的相互作用:对病毒融合机制的影响及融合抑制剂的鉴定
Lancet. 2004 Mar 20;363(9413):938-47. doi: 10.1016/S0140-6736(04)15788-7.

引用本文的文献

1
Evaluation of the Immunity Responses in Mice to Recombinant Displaying Newcastle Disease Virus Protein Truncations.小鼠对展示新城疫病毒蛋白截短体的重组体的免疫反应评估。
Microorganisms. 2024 Feb 21;12(3):439. doi: 10.3390/microorganisms12030439.
2
Analysis of Amino Acid Changes in the Fusion Protein of Virulent Newcastle Disease Virus from Vaccinated Poultry in Nigerian Isolates.尼日利亚分离株中接种疫苗家禽的强毒新城疫病毒融合蛋白氨基酸变化分析
Int J Microbiol. 2022 Oct 31;2022:9979683. doi: 10.1155/2022/9979683. eCollection 2022.
3
Entry Inhibitors: Efficient Means to Block Viral Infection.进入抑制剂:阻断病毒感染的有效手段。
J Membr Biol. 2020 Oct;253(5):425-444. doi: 10.1007/s00232-020-00136-z. Epub 2020 Aug 30.
4
Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes.三萜类化合物通过包裹病毒包膜中普遍存在的 HR2 结构域来操纵广泛的病毒-宿主融合。
Sci Adv. 2018 Nov 21;4(11):eaau8408. doi: 10.1126/sciadv.aau8408. eCollection 2018 Nov.
5
Synthesis and chemical characterization of several perfluorinated sialic acid glycals and evaluation of their antiviral activity against Newcastle disease virus.几种全氟唾液酸缩水甘油的合成、化学表征及其对新城疫病毒的抗病毒活性评估
Medchemcomm. 2017 Jun 5;8(7):1505-1513. doi: 10.1039/c7md00072c. eCollection 2017 Jul 1.
6
Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein.鉴定和应用 SARS-CoV 刺突蛋白中的自结合拉链样序列。
Int J Biochem Cell Biol. 2018 Aug;101:103-112. doi: 10.1016/j.biocel.2018.05.012. Epub 2018 May 22.
7
Entry of Newcastle Disease Virus into the host cell: role of acidic pH and endocytosis.新城疫病毒进入宿主细胞:酸性pH值和内吞作用的作用
Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):300-9. doi: 10.1016/j.bbamem.2013.08.008. Epub 2013 Aug 28.
8
Paramyxovirus entry.副黏病毒进入。
Adv Exp Med Biol. 2013;790:95-127. doi: 10.1007/978-1-4614-7651-1_6.
9
The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain.新城疫病毒的基质(M)蛋白通过其 BH3 结构域与人 bax 结合。
Virol J. 2011 Aug 3;8:385. doi: 10.1186/1743-422X-8-385.
10
Hendra and nipah infection: pathology, models and potential therapies.亨德拉病毒和尼帕病毒感染:病理学、模型及潜在疗法
Infect Disord Drug Targets. 2011 Jun;11(3):315-36. doi: 10.2174/187152611795768097.

本文引用的文献

1
Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion.
J Biol Chem. 1998 Oct 16;273(42):27182-90. doi: 10.1074/jbc.273.42.27182.
2
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41.猴免疫缺陷病毒糖蛋白41(SIV gp41)44 kDa胞外域的三维溶液结构
EMBO J. 1998 Aug 17;17(16):4572-84. doi: 10.1093/emboj/17.16.4572.
3
A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.副粘病毒融合蛋白的核心三聚体:与流感病毒血凝素和HIV-1 gp41的相似之处。
Virology. 1998 Aug 15;248(1):20-34. doi: 10.1006/viro.1998.9242.
4
HIV entry and its inhibition.HIV病毒的侵入及其抑制
Cell. 1998 May 29;93(5):681-4. doi: 10.1016/s0092-8674(00)81430-0.
5
Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus.切割突变体对新城疫病毒野生型融合蛋白介导的合胞体形成的影响。
J Virol. 1998 May;72(5):3789-95. doi: 10.1128/JVI.72.5.3789-3795.1998.
6
Capture of an early fusion-active conformation of HIV-1 gp41.捕获HIV-1 gp41的早期融合活性构象。
Nat Struct Biol. 1998 Apr;5(4):276-9. doi: 10.1038/nsb0498-276.
7
A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. A plausible mode of action.一种源自仙台病毒融合蛋白保守结构域的肽可抑制病毒与细胞的融合。一种可能的作用方式。
J Biol Chem. 1998 Mar 27;273(13):7252-9. doi: 10.1074/jbc.273.13.7252.
8
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.由gp41合成肽的抑制作用揭示的人类免疫缺陷病毒1型包膜糖蛋白融合孔的扩张
J Cell Biol. 1998 Jan 26;140(2):315-23. doi: 10.1083/jcb.140.2.315.
9
Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.使用生物学测定、核磁共振(NMR)和分子建模对副粘病毒(新城疫病毒,NDV)融合肽抑制剂进行分析。
Virology. 1997 Nov 24;238(2):291-304. doi: 10.1006/viro.1997.8834.
10
A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus.仙台病毒融合蛋白胞外域中的亮氨酸拉链基序在溶液和膜中组装,并特异性结合生物活性肽和病毒。
Biochemistry. 1997 Dec 9;36(49):15451-62. doi: 10.1021/bi971152i.